Author:
Evans Marc,Morgan Angharad R.,Bain Stephen C.,Davies Sarah,Hicks Debbie,Brown Pam,Yousef Zaheer,Dashora Umesh,Viljoen Adie,Beba Hannah,Strain W. David
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference55 articles.
1. International Diabetes Federation (IDF). IDF diabetes atlas. Ninth edition 2019. 2019. https://www.diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf. Accessed 28 July 2021.
2. Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.
3. Paul SK, Klein K, Thorsted BL, Wolden ML, Khunti K. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol. 2015;14:100.
4. NHS Digital. National Diabetes Audit (NDA) 2020–2021 quarterly report for England, Clinical Commissioning Groups and GP practices—PROVISIONAL. 2021. https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/care-processes-and-treatment-targets-3rd-quarter-january-december-2020-data-release. Accessed 14 Sep 2021.
5. DeFronzo RA. Combination therapy with GLP-1 receptor agonist and SGLT2 inhibitor. Diabetes Obes Metab. 2017;19(10):1353–62.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献